Year: 2026
Type: article
Abstract: Radiotheranostics has achieved clinical maturity, yet preclinical development remains reliant on animal studies. Direct, dynamic measurement of radionuclide distribution offers a distinctive opportunity to develop quantitative New Approach Methodology (NAM) frameworks. We propose integrating human-relevant models, radionuclide sensing, historical biodistribution data and AI-assisted computational prediction. Fit-for-purpose validation, defined contexts of use and domains of applicability, and quantified predictive uncertainty could support reliable translational decisions and enable development beyond animal-first pipelines.
Source: npj Imaging
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,790
OpenAlex ID: W7226644201
